Results 91 to 100 of about 3,430 (196)

Glomérulonéphrite extramembraneuse anti-PLA2R+ : 39 ans d’activité sans insuffisance rénale !

open access: yes, 2020
Objectif : Rapporter un cas de Glomérulonéphrite extra membraneuse anti-PLA2R+ évoluant depuis 39 ans, sans insuffisance rénale. Observation : Le diagnostic histologique de syndrome néphrotique à lésions glomérulaires minimes fut posé en 1980 chez une ...
Jadoul, Michel   +5 more
core  

Clinical Outcomes of Immunosuppressive Therapy in Patients with Seronegative Anti- PLA2R Antibodies and PLA2R-Related Membranous Nephropathy

open access: yesClinical and Experimental Nephrology
Abstract Background Idiopathic membranous nephropathy (IMN) is an autoimmune disease characterized by anti-PLA2R antibodies, which are linked to disease activity, prognosis, and relapse. While guidelines recommend immunosuppressive treatment for high antibody levels, the impact on PLA2R-negative patients remains unclear.
Di Wu   +6 more
openaire   +2 more sources

Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN)

open access: yes, 2016
Autoantibodies to M-type phospholipase A2 receptor (PLA2R) are specific markers of idiopathic membranous nephropathy (IMN). They can differentiate IMN from other glomerular diseases and primary from secondary forms of MN.
Stellato, Tiziana   +13 more
core   +2 more sources

Immunohistochemical staining of PLA2R in glomerular deposits (ALP ×400).

open access: yes, 2016
(A) In patients with minimal change disease there is very weak expression of PLA2R on the glomerular potocytes and it is recognized as negative result in this study.
Xiao-hong Cheng (2805652)   +6 more
core   +1 more source

Exploring glomeruli and renal tubules transcriptomic data: Crucial role of the AASS gene in membranous nephropathy

open access: yes
Clinical and Translational Medicine, Volume 15, Issue 4, April 2025.
Congcong Jiao   +9 more
wiley   +1 more source

PLA2R Immunohistochemistry Staining in Membranous Glomerulopathy: A Challenging Stain to Interpret But a Potentially Useful Diagnostic Tool

open access: yes, 2021
Circulating autoantibodies to phospholipase A2 receptor (PLA2R-Ab) are detected in > 70% of patients with primary membranous glomerulonephritis (MGN).
Sciri, R   +6 more
core  

Serum Levels of BAFF and APRIL Predict Clinical Response in Anti-PLA2R-Positive Primary Membranous Nephropathy [PDF]

open access: yes, 2019
Primary membranous nephropathy (PMN) is a renal-specific autoimmune disease caused by circulating autoantibodies that target glomerular podocyte antigens (PLA2R/THSD7A).
Croce L.   +11 more
core   +1 more source

Association of M-Type Phospholipase A2 Receptor Deposition in Kidney Tissue with Treatment Outcomes in Patients with Idiopathic Membranous Nephropathy

open access: yesJournal of Inflammation Research, 2023
Ning-Qiu Xie,1,* Yu-Lin Zhang,2,* Zi-Li Zheng,1 Quan-Lin Zheng,1 Ruo-Ji Chen1 1Department of Nephrology, Jinjiang Municipal Hospital, Jinjiang, Fujian, 362200, People’s Republic of China; 2Department of Pediatric, Jinjiang Municipal Hospital ...
Xie NQ   +4 more
doaj  

The prevalence of glomerular PLA2R Ag expression in MN patients.

open access: yes, 2016
The prevalence of glomerular PLA2R Ag expression in MN patients.
Tomohiro Saito (659385)   +9 more
core   +1 more source

Rare coexistence of spinal muscular atrophy with membranous nephropathy – A clinical conundrum with management dilemma

open access: yesIndian Journal of Pathology and Microbiology
A 48-year-old male presented with proximal muscle weakness of the shoulder with difficulty in lifting objects above the shoulder in July 2012. Electromyogram was suggestive of chronic motor axonal loss with a myogenic pattern, and a deltoid muscle biopsy
Gerry G. Mathew   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy